Quest Diagnostics Incorporated to Issue Quarterly Dividend of $0.86 (NYSE:DGX)

Posted by Brian Himes on Aug 13th, 2026

Quest Diagnostics Incorporated (NYSE:DGX – Get Free Report) announced a quarterly dividend on Wednesday, August 12th. Shareholders of record on Tuesday, October 6th will be paid a dividend of 0.86 per share by the medical research company on Wednesday, October 21st. This represents a c) annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend is Tuesday, October 6th.

Quest Diagnostics has increased its dividend by an average of 0.1%per year over the last three years and has raised its dividend every year for the last 14 years. Quest Diagnostics has a dividend payout ratio of 32.7% meaning its dividend is sufficiently covered by earnings. Research analysts expect Quest Diagnostics to earn $11.95 per share next year, which means the company should continue to be able to cover its $3.44 annual dividend with an expected future payout ratio of 28.8%.

Quest Diagnostics Price Performance

DGX stock opened at $237.53 on Thursday. Quest Diagnostics has a 12-month low of $171.18 and a 12-month high of $240.13. The company has a current ratio of 1.59, a quick ratio of 1.46 and a debt-to-equity ratio of 0.72. The firm’s 50-day moving average price is $214.12 and its two-hundred day moving average price is $202.57. The stock has a market capitalization of $26.22 billion, a price-to-earnings ratio of 25.22, a PEG ratio of 2.19 and a beta of 0.56.

Quest Diagnostics (NYSE:DGX – Get Free Report) last posted its earnings results on Thursday, July 23rd. The medical research company reported $3.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.82 by $0.30. The firm had revenue of $3.04 billion for the quarter, compared to analysts’ expectations of $2.97 billion. Quest Diagnostics had a return on equity of 16.01% and a net margin of 9.18%.The business’s revenue was up 10.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.62 earnings per share. Quest Diagnostics has set its FY 2026 guidance at 11.050-11.250 EPS. As a group, equities analysts predict that Quest Diagnostics will post 11.15 earnings per share for the current year.

Quest Diagnostics Company Profile

(Get Free Report)

Quest Diagnostics (NYSE: DGX) is a leading provider of diagnostic information services that supports clinical decision-making for patients, physicians and healthcare organizations. The company operates a network of clinical laboratories and patient service centers that perform a broad range of laboratory tests and diagnostic assays used in routine care, disease diagnosis, monitoring and screening.

Its services span core clinical laboratory testing, anatomic pathology, molecular and genomic diagnostics, infectious disease testing and toxicology.